 |
The topic of this article may not meet Wikipedia's general notability guideline. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.
Find sources: "Quantitative Biosciences Institute" – news · newspapers · books · scholar · JSTOR (June 2022) (Learn how and when to remove this message) |
The Quantitative Biosciences Institute (QBI) was established in 2016 as an organized research unit (ORU) within the School of Pharmacy at the University of California-San Francisco.[1][2][3][4] The current director of QBI is Nevan Krogan.[5][1]
In 1993, Irwin Kuntz, created an ORU within the School of Pharmacy, called the Molecular Design Institute (MDI). The Dean of the School of Pharmacy, B. Joseph Guglielmo with the support of the UCSF campus and the UC Office of the President transformed MDI into QBI.[5]
Previously, QBI was a part of QB3, also known as QB3-UCSF.[4] In March 2016, UCSF established QBI as a Organized Research Unit (ORU) within the School of Pharmacy.[5]
The institute formed the QBI Coronavirus Research Group (QCRG), a collaborative group of labs, aimed at finding solutions for COVID-19.[1][2][6][7][8]
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
 | This California-related article is a stub. You can help Wikipedia by expanding it. |
 | This pharmacy-related article is a stub. You can help Wikipedia by expanding it. |
